Clinical Trial Update: Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports on the persistence of hepatitis A antibody in healthy adults roughly 32 years after vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Snippet

Sponsor: Best Healthcare Inc. | Conditions: Hepatitis A | Phase 4 | Status: UNKNOWN